Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.
Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 replaced the prior v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a detailed Locations section listing participating sites across the United States, Canada, United Kingdom, Australia, and Japan. This helps potential participants identify nearby sites and understand where the study is being conducted.SummaryDifference2%
- Check46 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check53 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and that the page now displays Revision: v3.3.1. Removed the older PubMed-origin wording and Revision: v3.2.0 reference.SummaryDifference0.0%
- Check60 days agoChange DetectedThe government funding status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check74 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page. The study design, eligibility criteria, and listed locations remain the same.SummaryDifference0.2%
Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.